Alzheimer’s disease (AD) is a slowly progressive disease that occurs in stages. Initially, the disease is mild, but, with time, it progresses and the symptoms of the final stages of Alzheimer’s disease can become severe. Eventually, Alzheimer’s disease affects most areas of your brain. Memory, thinking, judgment, language, problem-solving, personality, and movement can all be affected by the disease. The disease can last anywhere from 6-10 years and the duration of each stage may vary from 6 to 24 months in most cases. Observation of patients reveals the stages of Alzheimer’s disease with some overlap. Each person has a different experience with Alzheimer’s and its symptoms. Knowing the different stages allows healthcare workers to predict the prognosis. The five stages of AD include the following:
It is now known that Alzheimer’s disease starts way before any symptoms become obvious; this is known as preclinical AD. This stage is only identified by imaging studies done for some other reason. At this stage, the affected individual is asymptomatic. The preclinical stage may last 2-3 years, and, in some cases, it, may never progress. The only way to know if you have preclinical AD is to undergo a PET (positron emission tomography) scan, which can detect a protein called beta-amyloid. This protein is a hallmark of the disorder. Statistics have shown that close to 30 percent of individuals with preclinical AD will not have amyloid plaques in the brain. PET scans are now utilized for select patients only with early Alzheimer’s disease for clinical trials. The ability to identify these patients is especially important because today there are several novel therapies that can help break up the amyloid plaques. In addition, several additional biomarkers of the disease have been identified but usually, they only are positive in the presence of symptoms.
There are genetic tests to determine if one is at a higher risk for early-onset Alzheimer’s disease. However, these tests are only recommended for a few select patients and are not for routine use. They are more applicable in families with a high incidence of AD at a young age.
In most cases, individuals with early-stage Alzheimer’s disease may have mild cognitive impairment (MCI). These mild changes may affect the ability to think clearly and are also associated with intermittent forgetfulness. These effects are so mild that they do not impact work or personal relationships. The memory loss is usually linked to short-term memory, like forgetting where the car keys are kept, not remembering to turn off the water tap, or forgetting to switch off the TV. Further, these individuals may not have a proper grasp of the time it takes to accomplish a task or may not be able to complete a task that requires multiple steps. Finally, these individuals also have difficulty making sound decisions.
It is important to understand, however, that not all individuals with MCI have Alzheimer’s disease. The diagnosis of MCI is based on the history and clinical presentation. Healthcare workers may utilize a variety of screening tools to determine the presence of memory loss and cognitive dysfunction.
The majority of individuals with Alzheimer’s disease are diagnosed when they have mild dementia. The family notices that the individual is forgetful, losing things, having difficulty remembering recent events, and may also have mild problems with daily living activities. Individuals with mild dementia may experience the following:
As the disease progresses, moderate dementia will set in, which is marked by frequent episodes of forgetfulness and more confusion. The individual will start to need help for most daily living activities, like dressing and self-care. In general, individuals with moderate dementia will show the following features:
Severe dementia is the last stage of the disorder. At this stage, severe compromises in mental function and behavior are common. Some common symptoms of the final stages of Alzheimer’s disease include:
The rate of progression through the stages of Alzheimer’s disease varies from individual to individual. On average, once a diagnosis of AD is made, the individual may survive 3-10 years, but the rare individual may survive even longer. As the stages progress, and the symptoms of the final stages of Alzheimer’s disease persevere, the degree of mental and physical impairment becomes severe, and the quality of life is very poor. Other comorbid factors that worsen the prognosis of AD include:
The majority of Alzheimer’s patients have difficulty swallowing and aspiration of food and saliva into the lungs is not uncommon. The most common cause of death is pneumonia. Other causes of death include failure to thrive, malnutrition, falls, and infections.
Alzheimer’s disease is an agonizingly painful disorder for both the affected individual and the family/caregivers. As the stages of Alzheimer’s disease progress, these individuals are no longer able to live independently and most end up in a long-term care facility or hospice care, where the treatment is focused on comfort, easing pain, and meeting the emotional, physical, and spiritual needs of the individual and the family.
The professional staff at Cano Health stands ready to assist seniors with all their healthcare needs. Cano Health is dedicated to offering the best medical care and programs to seniors. During the difficult times of health crises, you need a support staff who will be there for you and your family. Discuss your options with the experts at Cano Health today by calling 1-855-208-7877.
We are thrilled to announce some exciting news at Cano Health! After nine months of…
The summer season brings with it sunshine, warmth, and a sense of adventure. Whether you're planning…
Living with arthritis doesn't mean giving up on an active lifestyle. In fact, regular exercise…
Anxiety and stress are common issues that affect many people in today's fast-paced and demanding…
Mental health is a critical aspect of our overall well-being. It affects our ability to…
Why does Colon Cancer happen? Colorectal cancer is a type of cancer that affects the…